190 likes | 296 Views
Treatment Demand Indicator in the Americas. Inter-American Drug Abuse Control Commission (CICAD), Organization of American States (OAS) National Drug Control Council of Chile (CONACE) Institute on Alcoholism and Drug Dependency of Costa Rica (IAFA).
E N D
Treatment Demand Indicator in the Americas Inter-American Drug Abuse Control Commission (CICAD), Organization of American States (OAS) National Drug Control Council of Chile (CONACE) Institute on Alcoholism and Drug Dependency of Costa Rica (IAFA) EMCDDA Annual Expert Meeting on Treatment Demand Indicator 25-26 September 2006 - Lisbon
Treatment Demand Indicator in the Americas • Luis Alfonzo: Demand Reduction Specialist CICAD, Washington D.C. • Patricia Contreras: National Drug Control Council of Chile (CONACE) • Julio Bejarano: Institute on Alcoholism and Drug Dependency of Costa Rica (IAFA)
It is composed of different uniform variables that provide useful data from drug treatment programs Allows for comparison of treatment facilities based on: -Treatment demand -Socio demographic profiles of clients and records of their previous treatments. -Other characteristics of users related to demand (most harmful drug, drug of first choice, age of first use) -Specific characteristics of a treatment center (infrastructure, facilities, equipment, supplies, human resources, etc.) Indicator Characteristics Treatment Demand as Indicator Allows for evaluation of the status of treatment centers in relation to the above
Multilateral Evaluation Mechanism(MEM CICAD OAS) Indicator # 11 CHARACTERISTICS OF DRUG TREATMENT AND REHABILITATION PROGRAMS (includes “Specific populations programs”)
SIDUC SCENARIOS - Emergency Rooms • Treatment Services • Medical Examiners Services • Household Surveys • Students Surveys • Detention Facilities • Uniform System for Drug Demand Indicators • Levels of information • Characteristics of drug users • Trends • Evaluation of program impact • Uniform or harmonized indicators
SIDUC-Data Sources • Treatment Services • Most harmful drug • Chronology of Problematic drug use • Age at first use • Route of administration • Frequency of use • Exclude: • Out-patients’ individualized treatment • Drug dependents not in treatment • Drug users at nationwide level • Main Indicators • Most problematic drug • Chronology of drug use • New products and patterns of drug use
Treatment Demand Indicators (CONACE, Chile) • National General Population Survey • Last year prevalence of drug use by gender, age and socio- economic status • Any substance (general) • First three substances of choice • Problematic drug use estimation: • Abuse: 190,000 people (37%) • Dependence: 150,000 people (29.6%) • Young people (12 to 18 years of age): 46,702 (44,2% ) • Want to enter treatment: 24,000 people (40.5%) Source: CONACE, 2006
Treatment Process Indicators • Route of Administration • Diagnostic Categories • Psychoactive substance use and mental disorders • Psychiatric comorbidity • Physical comorbidity • Biopsychosocial engagement • Motivational Status • Therapeutic Contract • Dropout • Treatment Program Adherence • Socio ocupational recovery Reinsertion • Therapeutic process monitoring • Partial: better, no change, worse • Outcomes: High achievement, intermediate, minimal Source: CONACE, 2006
Performance Indicator of Programs in Treatment Facilities • Domains to be monitored in programdevelopment: • Performance Capacity • Technical Capacity • Networking Capacity • Enter Registry data in COLABORA Data System Source: CONACE, 2006
Percent Distribution of Patients in Buenos Aires Metro Area Drug Treatment Facilities by Gender. 2005 SOURCE: OAD, 2005
Percent Distribution of Patients in Buenos Aires Metro Area Drug Treatment Facilities by Number of different drugs used during lifetime. 2005 SOURCE: OAD, 2005
Percent Distribution of Patients in Buenos Aires Metro Area Drug Treatment Facilities by type of drug that motivate to treatment. 2005 SOURCE: OAD, 2005
Addiction Surveillance System (SISVEA, Mexico) Source: SISVEA, Report 2005
Venezuelan Observatory on Drugs 21.84 % 2.27 % 24,11 % Source: Bulletin, National Antidrug Office (ONA) Venezuela, 2005
Distribution of patients dischargein drug treatment facilities by gender Costa Rica, 2001 – 2004 (Absolute values) Source: IAFA, 2005
Distribution of patients discharge from children and adolescent drug treatment facilities Costa Rica, 2001-2005 (Absolute values) Source: IAFA, 2005
Conclusions • Treatment indicators are not developed in most countries of the Americas • Data collection from drug treatment services remains irregular and insufficient • Even though young people in drug treatment are a substantial group, there is no current specific strategies to analyze the demand for treatment by this group
Luis Alfonzo B. [Lalfonzo@oas.org] Julio Bejarano [julio.bejarano@gmail.com] Patricia Contreras [pcontrerasp@conace.gov.cl]